Thermo Fisher sells cell culture, other businesses to GE
Jan 6 (Reuters) - Scientific and laboratory equipment maker Thermo Fisher Scientific Inc said it would sell its cell culture, gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Co, for about $1.06 billion.
The businesses, expected to have combined revenue of about $250 million in 2013, will become part of GE Healthcare's life sciences division, Thermo Fisher said in a statement.
The deal will allow GE to expand its technologies for the discovery and manufacturing of medicines, vaccines and diagnostics, GE said in a separate statement.
- Malaysia military tracked missing plane to west coast: source |
- Malaysia air probe finds scant evidence of attack: sources |
- Ukraine forms new defense force, seeks Western help |
- UPDATE 1-Missing Malaysian plane last seen at Strait of Malacca-source
- Freescale loss in Malaysia tragedy leads to travel policy questions